Image

A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency Diseases

Examining TAK-881's long-term safety in primary immunodeficiency patients.

Recruiting
2 years and older
All
Phase 3
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study is about checking the safety of TAK-881 when used for a long time in people with Primary Immunodeficiency Diseases (PIDD). PIDD is when the body's defense system doesn't work well. TAK-881 is a special medicine called an immunoglobulin (IgG) given through a drip. People in the study will get TAK-881 at the same level they had in an earlier study called TAK-881-3001. Every 2, 3, or 4 weeks, they will visit the clinic for a check-up. The study lasts at least 6 months, but some might continue for 2 more years if needed, depending on their test results.

  • Participants must have finished the earlier study, TAK-881-3001.
  • Clinic visits are every 12 weeks, with a possibility of 2 years of treatment.
  • Some risks include the need for informed consent and possible health impacts if new conditions appear.
Print
Study details
    Primary Immunodeficiency Diseases (PID)

NCT06076642

Takeda

11 May 2025

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.